Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Molson Coors Beverage Company Q1 Fiscal Year 2026 Earnings Call - Reaffirms Full-Year Guidance Amid Portfolio Shifts and Cost Pressures
Molson Coors delivered a mixed Q1 FY2026, with underlying EPS up 24% and pre-tax income up 16.2%, but U.S. beer volume share slipped 60 basis points as macro headwinds and regional competitive pressur...
- Underlying EPS surged 24% and pre-tax income rose 16.2% in Q1 FY2026, driven by pricing and cost discipline, despite a 0.1% constant-currency sales decline.
- U.S. beer volume share fell 60 basis points, with Miller Lite facing regional competitive pressures and Keystone Light requiring attention in the value segment.
- Molson Coors acquired Monaco Cocktails, adding immediate scale in the RTD space and retaining 80 sales personnel to bolster beyond-beer execution.
- +7 more takeaways
Pacira BioSciences Q1 2026 Earnings Call - EXPAREL Growth Accelerates Amid Strong Commercial Execution and Pipeline Catalysts
Pacira BioSciences delivered a robust first quarter in 2026, with total net sales rising as momentum from late 2025 carried forward. The flagship product EXPAREL led the charge, posting 7% volume grow...
- EXPAREL net sales reached $143.3 million in Q1 2026, up from $136.5 million in Q1 2025, driven by 7% volume growth despite vial mix shifts and a new GPO agreement.
- Commercial payer coverage for EXPAREL outside the surgical bundle has surpassed 110 million covered lives, supported by the NOPAIN Act and expanding market adoption.
- ZILRETTA sales increased 15% year-over-year to $26.8 million, fueled by a dedicated sales force and a strategic collaboration with Johnson & Johnson MedTech.
- +9 more takeaways
Flowserve Q1 2026 Earnings Call - Reaffirms $4.00-$4.20 EPS Amid Middle East Disruption and Strong Margin Expansion
Flowserve delivered a resilient first quarter in 2026, posting adjusted EPS of $0.85, up 18% year-over-year, and expanding adjusted operating margins by 230 basis points to 15.1%. The results reflect ...
- Adjusted EPS of $0.85 exceeded expectations, up 18% year-over-year, driven by 230 basis points of operating margin expansion and a $0.19 benefit from IEPA tariff refunds.
- Full-year adjusted EPS guidance remains unchanged at $4.00-$4.20, implying mid-single-digit growth over 2025, despite Q1 headwinds.
- Revenue fell 7% to $1.1 billion, hampered by a 2% negative impact from Middle East disruptions and a softer start to North American MRO bookings in January and February.
- +7 more takeaways
LPL Financial Q1 2026 Earnings Call - Record EPS and Commonwealth Integration Progress Drive Operating Leverage
LPL Financial delivered a strong start to 2026 with record adjusted EPS of $5.60, up 9% year-over-year, driven by organic growth and disciplined expense management. Total assets declined to $2.3 trill...
- LPL Financial reported record adjusted EPS of $5.60, a 9% increase year-over-year, reflecting strong financial performance despite macro headwinds.
- Total client assets declined to $2.3 trillion as market depreciation offset $21 billion in organic net new assets, achieving a 4% annualized growth rate.
- The firm advanced its integration with Commonwealth Financial Network, targeting 90% asset retention by year-end, with current retention in the mid-80s.
- +7 more takeaways
Amgen
Amgen delivered a strong first quarter of 2026, driving 4% product sales growth that outpaced the drag from patent expirations on legacy brands like Prolia and Xgeva. The company’s six key growth driv...
- Amgen’s six key growth drivers, including Repatha, Tezspire, and Uplizna, generated 70% of product sales in Q1 2026 and grew 24% year-over-year.
- Product sales rose 4% year-over-year, outpacing the financial impact of patent expirations on legacy brands like Prolia and Xgeva.
- MariTide, a long-acting antibody-peptide conjugate for obesity and type 2 diabetes, initiated two new phase III studies evaluating monthly, every-eight-week, and every-12-week dosing schedules.
- +7 more takeaways
TETRA Technologies Q1 2026 Earnings Call - Record Q1 Revenue Driven by Deepwater Growth and Strategic Critical Minerals Expansion
TETRA Technologies delivered a standout first quarter of 2026, recording 10-year highs in revenue and adjusted EBITDA despite a turbulent macro backdrop. The company’s strategic pivot toward deepwater...
- Q1 2026 revenue reached $156 million, a 10-year high, while adjusted EBITDA hit $26 million, also a 10-year high, excluding the prior year’s Neptune project tailwind.
- The industrial chemicals sub-segment posted record revenue, up 15% year-over-year and 13% quarter-over-quarter, now representing over 50% of total segment revenue.
- Deepwater completion fluids in Brazil and the Gulf of Mexico achieved 10-year highs, with growing demand for higher-density zinc bromide fluids in hotter, deeper wells.
- +9 more takeaways
A. O. Smith Q1 2026 Earnings Call - China Slump and DOE Delay Force Cut, but North America Pricing and Leonard Valve Integration Hold the Line
A. O. Smith reported a tough start to 2026, with total sales down 2% to $946 million as a 17% plunge in China and soft North American residential demand offset the $16 million contribution from the ne...
- Total sales declined 2% to $946 million, driven by an 11% drop in Rest of World sales and a 1% increase in North America sales.
- EPS fell 11% to $0.85, pressured by lower residential water heater volumes, weather-related production constraints, and $0.03 in Leonard Valve transaction expenses.
- North America residential water heater sales fell 2% due to adverse weather at the Ashland City, Tennessee facility and soft new construction demand.
- +10 more takeaways
BlueLinx Holdings Q1 2026 Earnings Call - Margin Expansion Amid Soft Housing Demand
BlueLinx Holdings delivered a resilient first quarter in 2026, posting net sales of $731 million and adjusted EBITDA of $23.5 million. The results were driven by disciplined execution of its specialty...
- Net sales increased 3% year-over-year to $731 million, driven by specialty product volume growth and the Disdero acquisition.
- Adjusted EBITDA rose approximately 20% to $23.5 million, reflecting improved gross margins and disciplined expense management.
- Specialty products accounted for 70% of net sales and 80% of gross profit, underscoring the success of the mix-shift strategy.
- +9 more takeaways
Saia Inc Q1 2026 Earnings Call - Record Revenue and Margin Leverage as National Network Matures
Saia delivered a record first quarter for 2026, with revenue rising 2.4% to $806 million and shipments up 1% despite a sharp diesel price spike in March that created a temporary margin headwind. The c...
- Record Q1 2026 revenue of $806.2 million, up 2.4% year-over-year, driven by a 1% increase in shipments per workday and higher fuel surcharge revenue.
- Fuel surcharge revenue jumped 12.3%, now representing 16.5% of total revenue, but a rapid 30% diesel price spike in March created a $3.5 million margin headwind due to weekly surcharge lag.
- Shipment growth broadened across the network, with legacy terminals posting their first quarter-over-quarter growth in five quarters while new, ramping facilities continued to outperform.
- +7 more takeaways
UFP Industries Q1 2026 Earnings Call - Deckorators Growth Offsets Residential Construction Weakness
UFP Industries reported a disappointing Q1 2026, with net sales down 8% and adjusted EBITDA margin contracting to 7.6%, driven by a prolonged winter, soft residential construction demand, and higher m...
- Net sales of $1.5 billion fell 8% year-over-year, reflecting a 7% decline in units and a 1% decrease in pricing.
- Adjusted EBITDA margin contracted to 7.6% from 8.9% in the prior year period, primarily due to Site-Built weakness and higher medical and transportation costs.
- Deckorators segment delivered 2% unit growth, led by 27% growth in Surestone decking and 4% growth in wood plastic composite decking.
- +7 more takeaways